Doxinis

(Cefpodoxime Proxetil 100 mg /200 mg Tablets)


Overview:

DOXINIS Tablets contains Cefpodoxime Proxetil. Cefpodoxime proxetil has a similar spectrum of antibacterial activity to the parenteral cephalosporins ceftriaxone and cefotaxime and a long elimination half-life, which allows once- or twice-daily administration. Cefpodoxime proxetil has proven efficacy in the treatment of community-acquired pneumonia and upper respiratory tract, skin and soft tissue and urinary tract infections.

 

Cefpodoxime is a third-generation cephalosporin bactericidal agent that acts by inhibition of bacterial cell-wall synthesis.

DOXINIS 100 Tablets can be used in the treatment of the following conditions:

  • Pharyngitis/tonsillitis
  • Acute community-acquired pneumonia
  • Acute bacterial exacerbation of chronic bronchitis
  • Uncomplicated gonorrhea
  • Skin and skin structure
  • Acute maxillary sinusitis
  • Uncomplicated urinary tract infection
100 mg every 12 hours for 10 – 14 days.
Cephalosporin is a bactericidal agent that acts by inhibition of bacterial cell-wall synthesis.

Related Products